Eledon Pharmaceuticals Sortino Ratio
| ELDN Stock | | | USD 3.90 0.08 2.09% |
The Sortino Ratio measures risk-adjusted return using only downside deviation rather than total volatility. Unlike the Sharpe Ratio, which penalizes both upside and downside volatility equally, the Sortino Ratio penalizes only returns below a target threshold, making it a more targeted measure of harmful volatility. Below is Eledon Pharmaceuticals's current Sortino Ratio with peer comparisons and related risk metrics.
Current Sortino Ratio Value
With Sortino Ratio at 0.2526, Eledon Pharmaceuticals shows its current reading on this measure. This reflects Eledon Pharmaceuticals's positioning relative to its own recent range within Biotechnology.
Sortino Ratio | = | ER[a] - ER[b]DD |
| = | 0.2526 | |
| ER[a] | = | Expected return on investing in Eledon Pharmaceuticals |
| ER[b] | = | Expected return on market index or selected benchmark |
| DD | = | Downside Deviation |
Sortino Ratio Peers Comparison
Eledon Pharmaceuticals's Sortino Ratio of 0.2526 falls above the 0.09 peer average. Values range from 0.0031 (Vanda Pharmaceuticals) to 0.2022 (Atea Pharmaceuticals), with wide dispersion across the group. Eledon Pharmaceuticals's risk-adjusted return exceeds the peer average, indicating more efficient compensation for risk taken.
Sortino Ratio Relative To Other Indicators
The chart below plots Sortino Ratio against Maximum Drawdown for Eledon Pharmaceuticals and its peers. Each point represents one equity — position along the horizontal axis shows Sortino Ratio while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Eledon Pharmaceuticals shows nearly
93.74 of Maximum Drawdown per unit of Sortino Ratio (
0.25 versus
23.68 ). This indicates Maximum Drawdown substantially exceeds Sortino Ratio for Eledon Pharmaceuticals.
Methodology, Assumptions & Data Sources
Eledon Pharmaceuticals has a current Sortino Ratio reading of 0.2526. Sortino Ratio for Eledon Pharmaceuticals is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Eledon Pharmaceuticals operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators